家族性精子鞭毛多发形态异常(MMAF)病例的全外显子组测序揭示新的DNAH1突变
该回顾性遗传学研究对来自伊朗和意大利的6个家系中10名MMAF患者进行全外显子组测序,在6个家系中的2个家系发现DNAH1基因的致病突变,共在12名受检者中的5名(41.7%)检出DNAH1突变,未发现新候选基因。研究证实DNAH1是MMAF综合征的主要相关基因之一,全外显子组测序可作为Sanger测序的替代方法用于严重男性不育表型的遗传诊断。
要点
- 在6个MMAF家系中,全外显子组测序在2个家系中检出DNAH1致病突变。
- 12名受检者中5名(41.7%)检出DNAH1突变;仅计入先证者时为6名中2名(33%)。
- c.8626-1G>A变异在伊朗人群MMAF患者中相对常见,且经RT-PCR和免疫组化证实无RNA或蛋白表达。
核心结论
- 研究证实DNAH1是MMAF综合征的主要相关基因之一,全外显子组测序是Sanger测序的良好替代方法,可用于严重男性不育表型的遗传诊断。
研究设计与样本
- 回顾性遗传学研究,纳入2008年至2015年间在伊朗和意大利招募的MMAF表型患者。
- 对总共10名受试者进行全外显子组测序,所有发现的变异均经Sanger测序确认。
- 另对2名受影响家庭成员进行直接Sanger测序分析。
- 对38名来自伊朗同一地理来源的额外MMAF患者进行靶向测序,以确定伊朗家系中所发现DNAH1突变的患病率。
主要发现
- 6个家系的全外显子组测序在2个家系中鉴定出致病突变。
- 另2名受影响家庭成员被确认与其同胞携带相同的纯合突变。
- 总共在12名受检者中的5名(41.7%)检出DNAH1突变;仅计入先证者时,6名受检MMAF个体中检出2名突变者(33%)。
- 在38名额外伊朗MMAF患者中,1名患者携带c.8626-1G>A变异,证实该变异在伊朗人群中相对常见。
- RT-PCR和免疫组化证实c.8626-1G>A变异的效果为受影响男性精子中观察不到RNA或蛋白。
关键数值与推荐
- 全外显子组测序可扩增所有编码外显子的80-90%。
- DNAH1基因较大,含78个外显子,使用传统Sanger测序方法进行测序具有挑战性且昂贵。
临床怎么用
- 作者认为全外显子组测序是Sanger测序的良好替代方法,可用于严重男性不育表型患者的遗传诊断。
局限性
- 全外显子组测序仅允许扩增所有编码外显子的80-90%,可能有些DNAH1外显子未被测序而遗漏一些额外突变。
- 全外显子组测序不能识别深部内含子突变,且检测大基因组事件(缺失、插入、倒位)效率不高。
- 在6个受检家系中的4个家系中,未在DNAH1或其他候选基因中鉴定出任何致病突变,这表明技术和/或数据分析可改进以提高诊断效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can whole-exome sequencing (WES) of patients with multiple morphological abnormalities of the sperm flagella (MMAF) identify causal mutations in new genes or mutations in the previously identified dynein axonemal heavy chain 1 (DNAH1) gene? SUMMARY ANSWER: WES for six families with men affected by MMAF syndrome allowed the identification of DNAH1 mutations in four affected men distributed in two out of the six families but no new candidate genes were identified. WHAT IS KNOWN ALREADY: Mutations in DNAH1, an axonemal inner dynein arm heavy chain gene, have been shown to be responsible for male infertility due to a characteristic form of asthenozoospermia called MMAF, defined by the presence in the ejaculate of spermatozoa with a mosaic of flagellar abnormalities including absent, coiled, bent, angulated, irregular and short flagella. STUDY DESIGN, SIZE, DURATION: This was a retrospective genetics study of patients presenting a MMAF phenotype. Patients were recruited in Iran and Italy between 2008 and 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: WES was performed for a total of 10 subjects. All identified variants were confirmed by Sanger sequencing. Two additional affected family members were analyzed by direct Sanger sequencing. To establish the prevalence of the DNAH1 mutation identified in an Iranian family, we carried out targeted sequencing on 38 additional MMAF patients of the same geographical origin. RT-PCR and immunochemistry were performed on sperm samples to assess the effect of the identified mutation on RNA and protein. MAIN RESULTS AND THE ROLE OF CHANCE: WES in six families identified a causal mutations in two families. Two additional affected family members were confirmed to hold the same homozygous mutation as their sibling. In total, DNAH1 mutations were identified in 5 out of 12 analyzed subjects (41.7%). If we only include index cases, we detected two mutated subjects out of six (33%) tested MMAF individuals. Furthermore we sequenced one DNAH1 exon found to be mutated (c.8626-1G > A) in an Iranian family in an additional 38 MMAF patients from Iran. One of these patients carried the variant confirming that this variant is relatively frequent in the Iranian population. The effect of the c.8626-1G > A variant was confirmed by RT-PCR and immunochemistry as no RNA or protein could be observed in sperm from the affected men. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: WES allows the amplification of 80-90% of all coding exons. It is possible that some DNAH1 exons may not have been sequenced and that we may have missed some additional mutations. Also, WES cannot identify deep intronic mutations and it is not efficient for detection of large genomic events (deletions, insertions, inversions). We did not identify any causal mutations in DNAH1 or in other candidate genes in four out of the six tested families. This indicates that the technique and/or the analysis of our data can be improved to increase the diagnosis efficiency. WIDER IMPLICATIONS OF THE FINDINGS: Our findings confirm that DNAH1 is one of the main genes involved in MMAF syndrome. It is a large gene with 78 exons making it challenging and expensive to sequence using the traditional Sanger sequencing methods. We show that WES sequencing is good alternative to Sanger sequencing to reach a genetic diagnosis in patients with severe male infertility phenotypes. STUDY FUNDING/COMPETING INTERESTS: This work was supported by following grants: the 'MAS-Flagella' project financed by the French ANR and the DGOS for the program PRTS 2014 and the 'Whole genome sequencing of patients with Flagellar Growth Defects (FGD)' project financed by the Fondation Maladies Rares for the program Séquençage à haut débit 2012. The authors have no conflict of interest.
引用
- Amiri-Yekta A, Coutton C, Kherraf ZE, et al. Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations. Hum Reprod. 2016. PMID: 27798045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。